Lunai Bioworks Inc.LNAI

Market cap
$31.74M
P/E ratio
Mar 31,
2012
Mar 31,
2013
Dec 31,
2014
Jun 30,
2016
Jun 30,
2017
Jun 30,
2018
Jun 30,
2019
Jun 30,
2021
Jun 30,
2022
Jun 30,
2023
Jun 30,
2024
NET LOSS-29,945-37,589-2,370,883-1,735,239-2,392,830471-18,016,480-26,723,607-113,433,392-39,684,056-80,650,172
Depreciation and amortization--45,20127,39514,528371,709123,535123,590113,496121,859
Change in fair value of contingent consideration--------3,048,0333-5
Loss on extinguishment of debt-----------1,303,578
Non-cash stock-based compensation expense----------5
Non-cash restricted shares issued for services rendered---------228,0005
Intangible asset impairment----------43
Goodwill impairment----------12
Amortization of discount on note payable--------296,505-297,212-348,621580,605
Insurance receivable-----471,641-108,005-119,831-342-1,594-461
Prepaid expenses/deposits----19,828138,841160,940-733,739-461,310-1,070,249-1,082,267
Accounts payable--162,950574,975-652,785119,575-29,946-272,318144
Other current liabilities-------30,00424,056-54,060-
Operating leases, net----------27,22411,284
Accrued expenses----------578,8095
NET CASH USED IN OPERATING ACTIVITIES-24,945-30,092-2,034,175-1,472,289--4,338,269-8,507,341-20,610,723-15,732,336-11,774,549-10,971,430
Notes receivable prior to acquisition----------1
Cash received from acquisition, net----------65,851
Purchase of property and equipment-----30,000716,66948,8925,15629,77470,430
NET CASH USED IN INVESTING ACTIVITIES-13,219-13,219-1,952,0341--575,732-716,669-48,892-5,156-29,774-1,260,179
Repayments of finance agreement----------870,073
Proceeds from exercise of warrants------682,056130,0002341,865
Proceeds from private placements-------5-43
Proceeds from issuance of promissory notes----------4
Proceeds from convertible notes payable----413,670-----4
NET CASH PROVIDED BY FINANCING ACTIVITIES38,50075,0007--176334511
 Effect of exchange rates on cash---------5,240-8,39560,141
NET INCREASE (DECREASE) IN CASH-------12-11,492,268-7,297,662-1,654,013
Interest------4389,22479,716352,33420,128
Income Taxes----64,003--3734--
Finance agreement entered into in exchange for prepaid assets-------607,250666,8751906,834
Conversion of note payable for issuance of preferred stock----------2
Note payable settled through non-cash exercise of warrants----------2
Debt discount related to notes payable----------339,342
Common shares issued upon acquisition----------136
Contingent consideration issued upon acquisition----------21
Common shares issued upon settlement of debt----------10
Earn out shares issued in settlement of contingent liability----------4
Options issued in settlement of debt----------489,000
Settlement of notes payable----------418,503